News

Monopar Therapeutics Showcases Groundbreaking Wilson Disease Data

Monopar Therapeutics Showcases Groundbreaking Wilson Disease Data

Monopar Therapeutics Highlights Significant ALXN1840 Findings

Monopar Therapeutics Inc. (Nasdaq: MNPR), a promising clinical-stage biopharmaceutical company, has recently announced an exciting development in their ongoing efforts to address unmet medical needs among patients. The company is set to present groundbreaking data concerning the ALXN1840 (tiomolybdate choline) drug candidate, aimed at treating Wilson disease, during a prestigious late-breaker poster presentation at the European Association for the Study of the Liver (EASL) International Liver Congress 2025.

Significant Presentation at EASL Congress 2025

The EASL Congress is known for being one of the premier platforms for hepatology research, where leading experts gather to share their latest findings. This year, the congress will take place in Amsterdam, from May 7 to May 10, offering a unique opportunity for Monopar to showcase their latest research.

Being selected for a late-breaker presentation is a notable achievement, as it signifies the importance and relevance of the findings being shared. Late-breakers are reserved for the most recent and impactful research that could substantially influence the field. This is especially vital for clinical studies that are prospective in nature, enhancing the likelihood of significant contributions to medical understanding.

Details of the Late-Breaker Presentation

For those interested in the specifics of the presentation, here are the pertinent details:

  • Title: Sustained long-term clinical improvement in Wilson disease patients on tiomolybdate choline
  • Abstract Number: LB25251
  • Session: Late-breaker Posters
  • Date and Time: Wednesday, May 7, 8:30 a.m. CET
  • Presenter: Karl Heinz Weiss, M.D.
  • Location: Amsterdam, Netherlands

The findings presented in this late-breaker session are anticipated to provide insights into the long-term efficacy and safety of ALXN1840, potentially offering hope to those affected by Wilson disease.

About Monopar Therapeutics Inc.

Monopar Therapeutics is not just focused on ALXN1840 for Wilson disease; the company has a diverse portfolio of clinical-stage projects aimed at tackling various medical challenges. Their radiopharmaceutical programs include MNPR-101-Zr, which is being explored for imaging advanced cancers, alongside MNPR-101-Lu and MNPR-101-Ac225, both of which are in various stages of development for treating advanced cancers.

The commitment of Monopar to advancing innovative therapies underscores their role in the biopharmaceutical landscape, indicating their potential to significantly impact patient care in oncology and hepatology.

Stay Updated

For those eager to learn more about Monopar’s research and therapeutic advancements, additional details regarding the poster presentation will be made available on their official website on May 7.

Additionally, staying connected through social media is a great way to receive real-time updates and insights. You can follow Monopar on X at @MonoparTx and visit their LinkedIn page for further news and developments.

Frequently Asked Questions

What is ALXN1840 used for?

ALXN1840 is a drug candidate being developed for the treatment of Wilson disease, a genetic disorder that causes copper accumulation in the body.

When will the EASL Congress take place?

The EASL Congress will be held in Amsterdam from May 7 to May 10.

How significant is a late-breaker presentation?

Late-breaker presentations are important as they showcase the most recent and impactful research findings, often influencing future studies and clinical practices.

What other programs does Monopar have besides ALXN1840?

Monopar is also developing radiopharmaceuticals, including MNPR-101-Zr for imaging advanced cancers, and MNPR-101-Lu and MNPR-101-Ac225 for cancer treatment.

How can I stay updated on Monopar's developments?

You can follow Monopar on X and LinkedIn to receive the latest updates on their research and corporate activities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Paris Baguette Opens New Café in Novato, CA

Updated Category News Views 76

Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...

Continue Reading
BULL Faces Class Action After Regulatory Fines

Updated Category News Views 151

Webull's Financial Quake Shakes Investors You don't expect to wake up to news of a stock in freefall, but here we are with Webull (NASDAQ:BULL) cratering after some rough compliance problems came to light. On November 5, 2026, Webull's stock tumbled nearly 11% thanks to FINRA slapping them with a $4.2 million fine for failing to keep their anti-money laundering (AML) and...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 62

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 80

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 207

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 120

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 203

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 208

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 101

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading

Top 5 Most Recently Viewed Articles

Billor Partners with Leste Group to Expand Truck Operations

Updated Category News Views 421

Billor's Strategic Funding to Drive Growth MIAMI – Billor, dedicated to empowering truck drivers through entrepreneurial opportunities, recently secured a substantial $330 million credit facility from Leste Group, a globally recognized alternative investment manager. This impressive financial backing allows Leste Group to lease trucks from Billor, significantly...

Continue Reading
5G Impact on Real-Time Spectrum Analysis Growth to 648.46M

Updated Category News Views 165

Real-Time Spectrum Analysis Market Growth Drivers The real-time spectrum analysis (RTSA) market has shown remarkable growth, projected to reach USD 648.46 million by 2034. This surge is primarily fueled by the rapid expansion of 5G technology and advancements within the defense sector, creating increased demand for high-performance signal monitoring and analysis tools....

Continue Reading
Fangzhou Inc. Celebrates Recognition for High-Tech Innovations

Updated Category News Views 208

Fangzhou Inc. Recognized for High-Tech Innovation Fangzhou Inc. has achieved remarkable recognition with its H2H Smart Healthcare Innovation Platform being honored among the top high-tech products. This recognition reflects the company’s exceptional strides in the field of Internet healthcare solutions, marking a significant milestone in its innovative journey....

Continue Reading
Moderna Inc: What the Latest Trends Mean for Investors

Updated Category News Views 188

Understanding Moderna Inc's Recent Market Position Moderna Inc (NYSE: MRNA) has seen a notable shift in its market dynamics, particularly concerning its short interest levels. This metric has dropped by 12.38% since the last report, indicating a possible change in investor sentiment. What Does the Short Interest Percentage Tell Us? Currently, there are approximately 65.04...

Continue Reading
Major Sale Agreement for Advanced Hydrogen Power and Coates International

Updated Category News Views 453

Major Agreement Signed for Corporate Sale In a significant move within the energy sector, Mr. George J. Coates, the CEO, along with his son Gregory G. Coates, who serves as Vice President, have finalized a deal to sell their businesses - Advanced Hydrogen Power, Ltd. and Coates International Ltd. This agreement marks a pivotal moment for both companies, as they plan to...

Continue Reading